Quest Diagnostics (DGX) financials
Quest Diagnostics revenue and earnings by year
Quest Diagnostics's revenue was $11.0 billion in the fiscal year to December 31, 2025, up 11.8% from the year before. Net income was $992 million, 9.0% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 4.8% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.0 | 9.9 | 9.3 | 9.9 | 10.8 | 9.4 | 7.7 | 7.5 | 7.4 | 7.2 |
| Revenue growth | 11.8% | 6.7% | -6.4% | -8.4% | 14.3% | 22.1% | 2.6% | 1.7% | 2.6% | — |
| Gross profit | 3.7 | 3.2 | 3.1 | 3.4 | 4.2 | 3.6 | 2.7 | 2.6 | 2.7 | 2.6 |
| Gross margin | 33.2% | 32.9% | 33.0% | 34.7% | 39.0% | 38.5% | 34.8% | 34.6% | 36.2% | 36.0% |
| Operating income | 1.6 | 1.3 | 1.3 | 1.4 | 2.4 | 2.0 | 1.2 | 1.1 | 1.2 | 1.3 |
| Operating margin | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.7% | 17.7% |
| Net income | 1.0 | 0.9 | 0.9 | 0.9 | 2.0 | 1.4 | 0.9 | 0.7 | 0.8 | 0.6 |
| Net margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.4% | 8.9% |
| Diluted EPS | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.44 | $6.28 | $5.29 | $5.50 | $4.51 |
| Free cash flow | 1.4 | 0.9 | 0.9 | 1.3 | 1.8 | 1.6 | 0.9 | 0.8 | 0.9 | 0.8 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open DGX in Markets.
See also: DGX valuation and P/E history · DGX returns
No forecast, no recommendation. This page describes Quest Diagnostics from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.